Rivaroxaban with aspirin significantly improves cardiovascular outcomes: COMPASS trial

Rivaroxaban plus aspirin delivered net clinical benefit for patients with stable cardiovascular disease
Rivaroxaban plus aspirin delivered net clinical benefit for patients with stable cardiovascular disease